Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles F Manski

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Diagnostic testing and treatment under ambiguity: using decision analysis to inform clinical practiceCharles F Manski
Clinical Advances in Hematology & Oncology : H&O|February 5, 2025
Novel approaches to optimization of drug dosagesCharles F Manski
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2026
What is the general Welfare: Welfare economic perspectives on equityCharles F Manski
NEJM Evidence|February 6, 2024
Navigating Uncertainty in Immunotherapy RegimensCharles F Manski
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2018
Communicating uncertainty in policy analysisCharles F Manski
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Vaccination with partial knowledge of external effectivenessCharles F Manski
Health Economics|August 3, 2018
Response to commentaries on "Reasonable patient care under uncertainty"Charles F Manski
Epidemiology (Cambridge, Mass.)|February 22, 2020
Toward Credible Patient-centered Meta-analysisCharles F Manski
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2024
Toward Patient-Centered Drug Approval for Treatment of Rare DiseasesCharles F Manski
Epidemiology (Cambridge, Mass.)|September 24, 2024
Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with DoseCharles F Manski
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Diagnostic testing and treatment under ambiguity: using decision analysis to inform clinical practiceCharles F Manski
Clinical Advances in Hematology & Oncology : H&O|February 5, 2025
Novel approaches to optimization of drug dosagesCharles F Manski
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2026
What is the general Welfare: Welfare economic perspectives on equityCharles F Manski
NEJM Evidence|February 6, 2024
Navigating Uncertainty in Immunotherapy RegimensCharles F Manski
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2018
Communicating uncertainty in policy analysisCharles F Manski
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Vaccination with partial knowledge of external effectivenessCharles F Manski
Health Economics|August 3, 2018
Response to commentaries on "Reasonable patient care under uncertainty"Charles F Manski
Epidemiology (Cambridge, Mass.)|February 22, 2020
Toward Credible Patient-centered Meta-analysisCharles F Manski
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2024
Toward Patient-Centered Drug Approval for Treatment of Rare DiseasesCharles F Manski
Epidemiology (Cambridge, Mass.)|September 24, 2024
Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with DoseCharles F Manski
Pageof 5